porter et al have reported that pentoxifylline shows statistically significant superiority over placebo in a seven-center , double-blind , parallel group , randomized trial of outpatients with intermittent claudication secondary to chronic occlusive arterial disease .
C0030899
pentoxifylline
C0021775
intermittent claudication